Willow Biosciences

TSX-WLLW
Toronto Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#44409
Country Rank
#1883
Market Cap
3.73 M
Price
0.0254
Change (%)
16.67%
Volume
3.8 M

Willow Biosciences's latest marketcap:

3.73 M

As of 06/23/2025, Willow Biosciences's market capitalization has reached $3.73 M. According to our data, Willow Biosciences is the 44409th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 3.73 M
Revenue (ttm) 4.62 M
Net Income (ttm) -3,006,470.4
Shares Out 29.44 M
EPS (ttm) -0.11
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/11/2025
Market Cap Chart
Data Updated: 06/23/2025

Willow Biosciences's yearly market capitalization.

Willow Biosciences has seen its market value drop from C$50.49 M to C$3.73 M since 2019, representing a total decrease of 92.60% and an annual compound decline rate (CAGR) of 37.83%.
Date Market Cap Change (%) Global Rank
06/23/2025 C$3.73 M -45.04% 44409
12/31/2024 C$9.37 M -24.56% 39878
12/29/2023 C$12.42 M -12.68% 37368
12/30/2022 C$14.23 M -74.41% 35758
12/31/2021 C$55.6 M -50.8% 28331
12/31/2020 C$113 M 123.81% 21301
12/31/2019 C$50.49 M 23252

Company Profile

About Willow Biosciences Inc.

Willow Biosciences Inc. is a biotechnology company specializing in the development, production, and sale of plant-derived ingredients for various industries, including:

  • Consumer care
  • Food and beverage
  • Pharmaceutical products

Key Partnerships

The company has established strategic collaborations to enhance its capabilities:

  • SUANFARMA: Collaboration to develop anti-infective APIs through precision fermentation.
  • Laurus Labs: Multi-product development and licensing partnership for manufacturing active pharmaceutical ingredients (APIs).

Company Background

Founded in 2019, Willow Biosciences Inc. is headquartered in Calgary, Canada, and operates primarily in the United States.

Frequently Asked Questions

  • What is Willow Biosciences's (TSX-WLLW) current market cap?
    As of 06/23/2025, Willow Biosciences (including the parent company, if applicable) has an estimated market capitalization of $3.73 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Willow Biosciences global market capitalization ranking is approximately 44409 as of 06/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.